Brief: Lavipharm FY 2024 Earnings After Tax EUR 9.0 Million Versus EUR 1.87 Million Year Ago
19/03/2025 15:37
March 19 (Reuters) - Lavipharm SA LPHr.AT: FY 2024 EARNINGS AFTER TAX EUR 9.0 MILLION VERSUS EUR 1.87 MILLION YEAR AGO FY 2024 ADJUSTED EBITDA FROM ONGOING OPERATIONS AT EUR 10.4 MILLION VERSUS EUR 9.1 MILLION YEAR AGO FY 2024 TOTAL SALES BEFORE CLAWBACK-REBATES FROM CONTINUING OPERATIONS AT EUR 61.0 MILLION VERSUS EUR 54.3 MILLION YEAR AGO Further company coverage: [LPHr.AT] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY